Insmed Inc. buy Morgan Stanley
Start price
30.03.26
/
50%
€133.00
Target price
30.03.27
€184.08
Performance (%)
-32.30%
Price
29.07.26
?
Summary
This prediction is currently active. Massive losses of -32.30% have been the result for the BUY prediction by Morgan_Stanley. This prediction currently runs until 30.03.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | -2.283% | -2.283% |
| iShares Core DAX® | 1.717% | 3.368% |
| iShares Nasdaq 100 | -4.565% | -4.238% |
| iShares Nikkei 225® | -7.120% | -11.869% |
| iShares S&P 500 | -0.894% | 1.687% |
Comments by Morgan_Stanley for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) was upgraded by Morgan Stanley from "equal weight" to "overweight". They now have a $212.00 price target on the stock.
Ratings data for INSM provided by MarketBeat